1203. Molecular screening for Multi-drug Resistance Genes in Hospitalized Veterans
Session: Poster Abstract Session: Healthcare Epidemiology: MDR-Gram Negative Infections
Friday, October 5, 2018
Room: S Poster Hall
Background:

Gene-based screening is a tool to detect and track multi-drug resistant organisms (MDROs) in hospitalized patients. MDRO acquisition and colonization during the duration of a hospital stay and their persistence over time are not well described.

Methods:

A peri-anal swab was collected within 48H of admission from patients on medical wards and the MICU at the Washington DC VA Medical Center and repeat swabs were obtained day 7 and 14 on patients consenting to participate. Clinical and laboratory data from admission to 12mo post discharge was reviewed. Genes associated with VRE (VanA), ESBL (CTX-M), carbapenase-producing organisms or CPOs (OXA-23, OXA-51) and CREs (KPC,NDM,VIM, IMP, OXA-48) were tested on swabs by the Acuitas-MDRO Test (OpGen, Inc).

Results:

Between 7/2015 and 8/2016, 565 hospitalized patients were screened with 210 swabs collected from 182 subjects. One swab was non-evaluable. Subjects had a mean age 67.5±12.0y (26-94y, 38% ≥70yrs) and 39% received empiric antibiotics at admission. Subjects were hospitalized for 1037 cumulative bed-days (1-81d) with median LOS of 3d; 84% (152/182) had a stay of a week or less. Among those who remained hospitalized long enough for serial testing, 45% were willing or able to provide >1 swab. Those with >1 swab were significantly older (+4.9y, P=0.03), more likely to have to have been admitted for an infectious diagnosis (48% vs 24%, P=0.02). All subjects negative for MDRO genes on admission with >1 swab remained negative on serial sampling. Sixteen subjects (8.8%) had one or more genes present on screening and all three with >1 swab had persistence of that gene on repeat sampling. Genes harbored included CTX-M (4.4%), VanA (4.4%), OXA-51(0.6%), KPC (0.6%).

Conclusion:

The rate of occult MDRO colonization was low in our predominately elderly hospitalized patients. The majority of consenting participants were discharged before swabs could be repeated. Serial sampling revealed that results of swabs persisted over time in the same subject despite treatments received during hospitalization, including exposures to antibiotics. The identification of occult MDRO carriage during a hospitalization, even when obtained after admission, may have utility in guiding treatment for providers.

Sarah Alsamarai, MD1, Caitlin Biedron, MD1, Barrett Holen, MD2, Jesse Goodman, MD3, Bona Yoon, MPH4 and Angelike P. Liappis, MD, FIDSA1, (1)Washington DC Veterans Affairs Medical Center and The George Washington University Medical Center, Washington, DC, (2)Washington DC Veterans Affairs Medical Center and The George Washington University Medical Center, WASHINGTON, DC, (3)Washington DC Veterans Affairs Medical Center and Georgetown University, Washington DC, Washington, DC, (4)Washington DC Veterans Affairs Medical Center, Washington, DC

Disclosures:

S. Alsamarai, None

C. Biedron, None

B. Holen, None

J. Goodman, None

B. Yoon, None

A. P. Liappis, None

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.